Table 1 Baseline characteristics of patients according to second surgical approach
Lap | Op | |||
|---|---|---|---|---|
Variable | (n = 37) | (n = 32) | p value | |
Period | 2008–2014 | 6 (16%) | 24 (75%) | < 0.0001 |
2015–2022 | 31 (84%) | 8 (25%) | ||
Sex | Male | 24 (65%) | 23 (72%) | 0.53 |
Age, year | Mean ± SD | 71.0 ± 11.5 | 70.2 ± 9.7 | 0.76 |
BMI, kg/m2 | Mean ± SD | 24.6 ± 3.5 | 23.0 ± 3.4 | 0.064 |
Hemoglobin, g/dL | Mean ± SD | 12.0 ± 1.9 | 12.0 ± 1.9 | 1.00 |
Albumin, g/dL | Mean ± SD | 3.7 ± 0.5 | 3.7 ± 0.5 | 0.78 |
Comorbidity | Diabetes | 8 (21%) | 10 (31%) | 0.53 |
COPD | 0 (0%) | 3 (9%) | 0.095 | |
Hypertension | 19 (51%) | 13 (41%) | 0.37 | |
Ischemic heart disease | 4 (11%) | 3 (9%) | 1.00 | |
CKD | 2 (5%) | 2 (6%) | 1.00 | |
Cerebrovascular disease | 5 (14%) | 1 (3%) | 0.21 | |
CNS disorder | 1 (3%) | 3 (9%) | 0.33 | |
Chronic hepatitis / cirrhosis | 0 (0%) | 1 (3%) | 0.46 | |
Autoimmune disease | 0 (0%) | 1 (3%) | 0.46 | |
Anti-thrombotic therapy | 13 (35%) | 2 (6%) | 0.009 | |
Preoperative systemic chemotherapy | 0 (0%) | 1 (3%) | 0.46 |